It has previously been shown that knockdown of paxillin in highly metastatic osteosarcoma sub-lines M112 and 132 inhibits migration [39], which is in direct contrast to our observation that loss of paxillin in Saos-2 cells correlates with increased motility. The gene discussed is PXN; the disease is osteosarcoma.